98201920 - CRST

Information

  • Trademark
  • 98201920
  • Serial Number
    98201920
  • Filing Date
    September 28, 2023
    a year ago
  • Transaction Date
    December 31, 2024
    a month ago
  • Status Date
    December 31, 2024
    a month ago
  • Published for Opposition Date
    December 31, 2024
    a month ago
  • Location Date
    December 09, 2024
    a month ago
  • Status Code
    686
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    PEISECKI, MARK
  • Attorney Docket Number
    39957/3542CR
    Attorney Name
    Jonathan M. Gelchinsky
    Law Office Assigned Location Code
    L50
  • Owners
Mark Drawing Code
4
Mark Identification
CRST
Case File Statements
  • GS0051: Enzymes, nucleic acid molecules, and compounds and agents for modifying small RNAs with targeting agents for medical use, namely, use of the modified small RNAs in the gene editing industry; pharmaceutical preparations and therapeutic agents, namely, for gene therapy and mRNA regulation; pharmaceutical and biological preparations for medical use for the treatment of genetic and genomic disorders by gene therapy and mRNA regulation for use in human and animal therapeutics; pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders in humans and animals; pharmaceutical preparations for gene therapy and mRNA regulation
  • GS0011: Chemical and biological agents for scientific and research use, namely, for the modification of small RNAs with targeting agents and for regulating expression and levels of mRNA with the modified RNAs; enzymes for scientific and research purposes; enzyme preparations for use in modifying small RNAs and for use of modified small RNAs in the gene editing industry; Nucleic acid sequences for other than medical and veterinary purposes
  • GS0421: Research and development in the field of technology and engineering RNAs with targeting agents for use in gene therapy and mRNA regulation; development of new technology for others for enabling the engineering and modification of RNA with targeting agents, namely, developing molecular and cellular biology reagents, techniques, and assays for use in the gene editing industry
Case File Event Statements
  • 10/2/2023 - a year ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 10/12/2023 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 4/26/2024 - 9 months ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/15/2024 - 6 months ago
    8 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG
  • 10/4/2024 - 4 months ago
    13 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 10/4/2024 - 4 months ago
    10 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 10/4/2024 - 4 months ago
    9 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 10/4/2024 - 4 months ago
    12 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 10/4/2024 - 4 months ago
    11 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 10/30/2024 - 3 months ago
    16 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/30/2024 - 9 months ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 4/30/2024 - 9 months ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 4/30/2024 - 9 months ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 7/15/2024 - 6 months ago
    7 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR
  • 10/30/2024 - 3 months ago
    15 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/4/2024 - 2 months ago
    18 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 12/25/2024 - a month ago
    19 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 12/31/2024 - a month ago
    20 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 12/31/2024 - a month ago
    21 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 11/1/2024 - 3 months ago
    17 - ASSIGNED TO EXAMINER Type: DOCK
  • 10/30/2024 - 3 months ago
    14 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA